Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy
Open Access
- 31 January 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (9), 10174-10181
- https://doi.org/10.18632/oncotarget.7101
Abstract
Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapyKeywords
This publication has 21 references indexed in Scilit:
- Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow TransplantationBlood, 2013
- Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter studyHaematologica, 2012
- EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytesLeukemia, 2012
- Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implicationsHaematologica, 2010
- Extended diagnostic criteria for plasmacytoid dendritic cell leukaemiaBritish Journal of Haematology, 2009
- Identification of Leptomeningeal Disease in Aggressive B-Cell Non-Hodgkin's Lymphoma: Improved Sensitivity of Flow CytometryJournal of Clinical Oncology, 2009
- CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignanciesNeurology, 2007
- Comparison of Intensive Chemotherapy, Allogeneic, or Autologous Stem-Cell Transplantation As Postremission Treatment for Children With Very High Risk Acute Lymphoblastic Leukemia: PETHEMA ALL-93 TrialJournal of Clinical Oncology, 2007
- High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytologyBlood, 2005
- PRINCIPAL RESULTS OF THE MEDICAL RESEARCH COUNCIL'S 8th ACUTE MYELOID LEUKAEMIA TRIALThe Lancet, 1986